Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes

FEBS Letters

Volumn 478, Issue 1-2, 2000, Pages 178-182

  Muno, Daisaku ^a   Kominami, Eiki ^a   Mizuochi, Toshiaki ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Antigen presentation; Macrophage; Major histocompatibility complex; Phagosome

Indexed keywords

ANTIGEN; LATEX; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; PEPTIDE; PROTEASOME;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL FRACTIONATION; CELL LINE; CONTROLLED STUDY; CYTOSOL; FEMALE; INTERNALIZATION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; CATHEPSINS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSOL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; KINETICS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSPHERES; OVALBUMIN; PEPTIDE FRAGMENTS; PHAGOCYTOSIS; PHAGOSOMES; PROTEASE INHIBITORS;

MURINAE;

EID: 0034726108     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01849-4     Document Type: Article

References (19)

1. Germain R.N. Nature. 322:1986;687-689.
2. Bevan M.J. Nature. 325:1987;192-194.
3. Yewdell J.W., Bennink J.R. Cell. 27:1990;203-206.
4. Kropshofer H., Haemmerling G.J., Vogt A.B. Immunol. Rev. 172:1999;267-278.
5. Rock K.L. Immunol. Today. 17:1996;131-137.
6. Yewdell J.W., Norbury C.C., Bennink J. Adv. Immunol. 73:1999;1-77.
7. Pfeifer H.J.D., Wick M.J., Roberts R.L., Findlay K., Normak S.J., Harding C.V. Nature. 361:1993;359-362.
8. Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K.L. Proc. Natl. Acad. Sci. USA. 90:1993;4942-4946.
9. Harding C.V., Song R. J. Immunol. 153:1994;4925-4933.
10. Kovacsovics-Bankowski M., Rock K.L. Science. 267:1995;243-246.
11. Sousa C.L.E., Germain R.N. J. Exp. Med. 182:1995;841-851.
12. Bachmann M.F., Oxenius A., Pircher H., Hengartner H., Ashton-Richardt P.A., Tonegawa S., Zinkernagel R.M. Eur. J. Immunol. 25:1995;1739-1743.
13. Murphy K.M., Heimberger A.B., Loh D.Y. Science. 250:1990;1720-1723.
14. Ramachanda L., Song R., Harding C.V. J. Immunol. 162:1999;3263-3272.
15. Desjardins M., Huber L.A., Parton R.G., Griffiths G. J. Cell. Biol. 124:1994;677-688.
16. Mizuochi T., Yee S.T., Kasai M., Kakiuchi T., Muno T., Kominami E. Immunol. Lett. 43:1994;189-193.
17. Murata M., Miyashita S., Yokoo C., Tamai M., Hanada K., Hatakeyama K., Towatari T., Nikawa T., Katunuma K. FEBS Lett. 280:1991;307-310.
18. Oh Y.-K., Harding C.V., Swanson A. Vaccine. 15:1997;511-518.
19. Gromme M., Uytdehaag F.G.C.M., Janssen H., Calafata J., van Binnendijk S., Kenter M.J.H., Tulp A., Berwoerd D., Neefjes J. Proc. Natl. Acad. Sci. USA. 96:1999;10326-10331.